These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29933822)

  • 1. When and How to Treat Possible Cannabis Use Disorder.
    Lévesque A; Le Foll B
    Med Clin North Am; 2018 Jul; 102(4):667-681. PubMed ID: 29933822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic cannabinoid withdrawal: a new demand on detoxification services.
    Macfarlane V; Christie G
    Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the art treatments for cannabis dependence.
    Danovitch I; Gorelick DA
    Psychiatr Clin North Am; 2012 Jun; 35(2):309-26. PubMed ID: 22640758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care of the Patient Using Cannabis.
    Williams AR; Hill KP
    Ann Intern Med; 2020 Nov; 173(9):ITC65-ITC80. PubMed ID: 33137270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis Use Disorder in Adolescence.
    Simpson AK; Magid V
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):431-43. PubMed ID: 27338965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.
    Lee DC; Schlienz NJ; Peters EN; Dworkin RH; Turk DC; Strain EC; Vandrey R
    Drug Alcohol Depend; 2019 Jan; 194():500-517. PubMed ID: 30530238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cannabis withdrawal syndrome.
    Budney AJ; Hughes JR
    Curr Opin Psychiatry; 2006 May; 19(3):233-8. PubMed ID: 16612207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Cannabis Use Disorder: Current Science and Future Outlook.
    Sherman BJ; McRae-Clark AL
    Pharmacotherapy; 2016 May; 36(5):511-35. PubMed ID: 27027272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and consequences of cannabis dependence.
    Budney AJ; Moore BA
    J Clin Pharmacol; 2002 Nov; 42(S1):28S-33S. PubMed ID: 12412833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic changes induced by cannabinoid drugs and cannabis use disorder.
    Augustin SM; Lovinger DM
    Neurobiol Dis; 2022 Jun; 167():105670. PubMed ID: 35219856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic cannabinoid use disorder: an update for general psychiatrists.
    Grigg J; Manning V; Arunogiri S; Lubman DI
    Australas Psychiatry; 2019 Jun; 27(3):279-283. PubMed ID: 30663326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
    González S; Cebeira M; Fernández-Ruiz J
    Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Psychiatric Consequences of Cannabinoids.
    De Aquino JP; Sherif M; Radhakrishnan R; Cahill JD; Ranganathan M; D'Souza DC
    Clin Ther; 2018 Sep; 40(9):1448-1456. PubMed ID: 29678279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cannabis--abuse and consequences].
    Wøien VA; Horwitz H; Høgberg LC; Askaa B; Jürgens G
    Ugeskr Laeger; 2015 Feb; 177(6):. PubMed ID: 25650575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid abuse and addiction: Clinical and preclinical findings.
    Panlilio LV; Goldberg SR; Justinova Z
    Clin Pharmacol Ther; 2015 Jun; 97(6):616-27. PubMed ID: 25788435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of cannabis dependence].
    Laqueille X; Dervaux A
    Rev Prat; 2013 Dec; 63(10):1438-40. PubMed ID: 24579349
    [No Abstract]   [Full Text] [Related]  

  • 18. [Consumption of cannabis in adolescents].
    Phan O; Obradovic I; Har A
    Arch Pediatr; 2017 Jan; 24(1):91-95. PubMed ID: 27889374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial.
    Hjorthøj CR; Fohlmann A; Larsen AM; Gluud C; Arendt M; Nordentoft M
    Psychol Med; 2013 Jul; 43(7):1499-510. PubMed ID: 23040144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cognitive functions in individuals with synthetic cannabinoid use disorder and comparison to individuals with cannabis use disorder.
    Cengel HY; Bozkurt M; Evren C; Umut G; Keskinkilic C; Agachanli R
    Psychiatry Res; 2018 Apr; 262():46-54. PubMed ID: 29407568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.